KMG (NYSE:KMG), a global provider of specialty chemicals and
performance materials, today announced financial results for the
fiscal 2018 third quarter ended April 30, 2018.
2018 Third Quarter Financial Highlights
- Sales increased 45% from the third quarter of last year to a
record $118.6 million.
- GAAP diluted earnings per share doubled to $0.98 from $0.49 per
diluted share in the third quarter of fiscal 2017.
- Adjusted diluted earnings per share1 was a record $1.10
compared to $0.53 per share reported in the third quarter of last
year.
- GAAP net income increased to $15.6 million, compared to $6.1
million in the third quarter of last year.
- Adjusted EBITDA2 was a record $31.5 million, up 125% from $14.0
million in the third quarter of fiscal 2017.
- Operating cash flow increased to a record $21.5 million,
compared to $7.9 million in the third quarter of fiscal 2017.
“KMG achieved outstanding third quarter results, driven by
strong organic growth in both our electronic chemicals and
performance materials segments, as well as a significant
contribution from the acquisition of Flowchem,” said Chris Fraser,
KMG chairman and CEO. “Consolidated sales grew 45% year-over-year
and 4% sequentially to $118.6 million, setting another quarterly
record for KMG. Adjusted EBITDA and adjusted diluted earnings
per share also reached record levels, reflecting product volume
growth and continued efficiency improvements across our global
operations.”
Mr. Fraser continued, “Third quarter sales in our electronic
chemicals segment increased 10% year-over-year to a record $74.7
million, benefiting from product volume growth in each of our major
geographic regions. Despite higher freight costs, segment operating
income grew 28% year-over-year to $10.9 million, aided by increased
product volume, operating efficiencies and a favorable product mix.
“Our performance materials segment also generated record
results, with third quarter sales increasing 10% on a sequential
basis and more than tripling year-over-year to $44 million.
Supported by our global capabilities and innovative technology, our
pipeline performance business generated strong growth, with
favorable energy market dynamics contributing to increased demand
for our products and solutions that optimize pipeline throughput
and maximize performance and safety. We also experienced continued
growth in our wood treating chemicals business, which provides
products essential to preserve North America’s expansive wood-based
utility pole infrastructure. Overall, performance materials segment
operating income grew to $16 million, a new quarterly record for
this segment.”
Mr. Fraser concluded, “Considering our strong financial
performance through the first nine months of fiscal 2018, as well
as our expectations for continued growth in the fourth quarter of
our fiscal year, we are increasing our fiscal 2018 sales forecast
to $455-465 million, from $445-455 million previously, and
increasing our fiscal 2018 adjusted EBITDA guidance to $118-120
million, from $114-118 million.”
Consolidated results
Third
quarter Dollars in thousands, except EPS |
Fiscal 2018 |
|
Fiscal 2017 |
|
As Reported |
Adjusted |
As Reported |
Adjusted |
|
(GAAP) |
(non-GAAP)3 |
(GAAP) |
(non-GAAP)4 |
Net sales |
$118,647 |
|
$118,647 |
|
$81,616 |
|
$81,616 |
|
Operating income |
|
23,953 |
|
|
27,230 |
|
|
9,367 |
|
|
10,001 |
|
Operating margin |
|
20.2 |
% |
|
23.0 |
% |
|
11.5 |
% |
|
12.3 |
% |
Net income |
|
15,645 |
|
|
17,459 |
|
|
6,067 |
|
|
6,479 |
|
Diluted earnings per
share |
$0.98 |
|
$1.10 |
|
$ 0.49 |
|
$0.53 |
|
Nine months
ended April 30 Dollars in thousands, except EPS |
Fiscal 2018 YTD |
|
Fiscal 2017 YTD |
|
As Reported |
Adjusted |
As Reported |
Adjusted |
|
(GAAP) |
(non-GAAP)5 |
(GAAP) |
(non-GAAP)6 |
Net sales |
$343,162 |
|
$343,162 |
|
$237,182 |
|
$237,182 |
|
Operating income |
|
65,763 |
|
|
75,749 |
|
|
27,087 |
|
|
28,671 |
|
Operating margin |
|
19.2 |
% |
|
22.1 |
% |
|
11.4 |
% |
|
12.1 |
% |
Net income |
|
46,832 |
|
|
45,205 |
|
|
18,293 |
|
|
19,323 |
|
Diluted earnings per
share |
$3.16 |
|
$3.05 |
|
$ 1.50 |
|
$ 1.58 |
|
Business segment results
Electronic
Chemicals |
Third Quarter |
Third Quarter |
|
Nine Months |
Nine Months |
Dollars in
thousands |
Fiscal 2018 |
Fiscal 2017 |
Fiscal 2018 |
Fiscal 2017 |
|
As Reported |
As Reported |
As Reported |
As Reported |
|
(GAAP) |
(GAAP) |
(GAAP) |
(GAAP) |
Net sales |
$74,669 |
|
$68,141 |
|
$222,401 |
|
$204,829 |
|
Operating income |
|
10,889 |
|
|
8,509 |
|
|
34,877 |
|
|
26,153 |
|
Operating margin |
|
14.6 |
% |
|
12.5 |
% |
|
15.7 |
% |
|
12.8 |
% |
For the third fiscal quarter, the Electronic Chemicals segment
reported:
- Sales of $74.7 million, up 10% from the third quarter of fiscal
2017. The gain in sales reflected product volume growth in all
geographic regions and a more favorable product mix.
- Operating income of $10.9 million, up 28% from $8.5 million in
the same period of fiscal 2017. Operating income increased due to
product volume growth, operational efficiencies and product mix.
Operating margin improved to 14.6% compared to 12.5% in the
prior-year period.
- Adjusted EBITDA7 of $13.7 million, up 19.7% from $11.5 million
last year.
Performance MaterialsThe Performance Materials
segment consists of the pipeline performance business and the wood
treating chemicals business.
Performance
Materials |
Third Quarter |
Third Quarter |
|
Nine Months |
Nine Months |
Dollars in
thousands |
Fiscal 2018 |
Fiscal 2017 |
Fiscal 2018 |
Fiscal 2017 |
|
As Reported |
As Reported |
As Reported |
As Reported |
|
(GAAP) |
(GAAP) |
(GAAP) |
(GAAP) |
Net sales |
$43,978 |
|
$13,475 |
|
$120,761 |
|
$32,353 |
|
Operating income |
|
16,041 |
|
|
4,224 |
|
|
40,435 |
|
|
10,927 |
|
Operating margin |
|
36.5 |
% |
|
31.4 |
% |
|
33.5 |
% |
|
33.8 |
% |
For the third fiscal quarter, the Performance Materials segment
reported:
- Sales of $44.0 million versus $13.5 million in the same period
a year ago. Sales growth reflected the contribution from Flowchem,
as well as product volume growth in both industrial lubricants and
wood treating chemicals.
- Operating income of $16.0 million compared to $4.2 million last
year. The increase in operating income reflected the contribution
from Flowchem, as well as product volume growth in both industrial
lubricants and wood treating chemicals. Segment operating margins
were 36.5%, compared to 31.4% in the third quarter of 2017, due to
the contribution from Flowchem, as well as product volume growth in
both industrial lubricants and wood treating chemicals.
- Adjusted EBITDA8 of $20.2 million versus $4.8 million last
year.
Fiscal 2018 Outlook
- Sales: We increase our fiscal 2018
consolidated net sales forecast to $455-465 million, from our prior
guidance of $445-455 million.
- Adjusted EBITDA: We increase our adjusted
EBITDA forecast to $118-120 million, from our prior guidance of
$114-118 million, reflecting stronger growth expectations in both
our electronic chemicals and performance materials segments. Our
revised fiscal 2018 adjusted EBITDA forecast includes approximately
$8.0 million in stock-based compensation expense, unchanged from
our prior estimate.
- Depreciation and Amortization: Depreciation
and amortization expense is forecast to be approximately $30
million.
- Capital Expenditures: Capital expenditures are
forecast to be approximately $25 million, down from our prior
estimate of approximately $29 million.
With respect to the Company’s full year guidance of Adjusted
EBITDA, the Company is not able to provide a reconciliation of
these fiscal 2018 non-GAAP financial measures to the most
comparable GAAP measure without unreasonable efforts; certain items
that are included have not yet occurred and cannot be reasonably
predicted, and, accordingly, the probable significance of such
items cannot be determined at this time. The most comparable GAAP
measure and reconciling information that is unavailable, or not
reasonably predictable, would include restructuring and realignment
charges and acquisition and integration-related expenses.
Conference callDate: Monday June 11, 2018Time:
5:00 p.m. ETDial in: 844-316-8066 or 703-736-7353Conference ID:
1685029
The conference call will be webcast live via the “Investors”
section of the Company’s website at http://kmgchemicals.com.
If you are unable to listen live, the conference call will be
archived on the KMG website. A telephone replay of the call will
also be available for one week, starting at 8:00 p.m. ET on June
11, 2018. To access the call, dial 855-859-2056 (domestic) or
404-537-3406 (international) using conference ID 1685029.
About KMGKMG Chemicals, Inc., through its
subsidiaries, produces and distributes specialty chemicals and
performance materials for the semiconductor, industrial wood
preservation and pipeline and energy markets. For more information,
visit the Company's website at http://kmgchemicals.com.
The information in this news release includes certain
forward-looking statements that are based upon assumptions that in
the future may prove not to have been accurate and are subject to
significant risks and uncertainties, including statements as to the
future performance of the company. Although the company believes
that the expectations reflected in its forward-looking statements
are reasonable, it can give no assurance that such expectations or
any of its forward-looking statements will prove to be correct.
Factors that could cause results to differ include, but are not
limited to, successful performance of internal plans, product
development acceptance, the impact of competitive services and
pricing and general economic risks and uncertainties.
1 Non-U.S. GAAP measure. See Table 2 for reconciliation.
2 Non-U.S. GAAP measure. See Tables 1 and 1A for
reconciliation.
3 Non-U.S. GAAP measure. See Tables 2 and 2A for
reconciliation.
4 Non-U.S. GAAP measure. See Tables 2 and 2A for
reconciliation.
5 Non-U.S. GAAP measure. See Tables 2 and 2A for
reconciliation.
6 Non-U.S. GAAP measure. See Tables 2 and 2A for
reconciliation.
7 Non-U.S. GAAP measure. See Tables 1 and 1A for
reconciliation.
8 Non-U.S. GAAP measure. See Tables 1 and 1A for
reconciliation.
|
CONDENSED CONSOLIDATED STATEMENTS OF
INCOME(UNAUDITED)(In thousands,
except for per share amounts) |
|
|
Three Months Ended |
|
Nine Months Ended |
|
April 30, |
|
April 30, |
|
|
2018 |
|
|
|
2017 |
|
|
|
2018 |
|
|
|
2017 |
|
Net
sales |
|
$118,647 |
|
|
$81,616 |
|
|
$343,162 |
|
|
$237,182 |
|
Cost of
sales |
|
68,156 |
|
|
|
49,106 |
|
|
|
196,936 |
|
|
|
143,787 |
|
|
Gross profit |
|
50,491 |
|
|
|
32,510 |
|
|
|
146,226 |
|
|
|
93,395 |
|
|
|
|
|
|
|
|
|
Distribution expenses |
|
9,070 |
|
|
|
9,457 |
|
|
|
27,192 |
|
|
|
28,329 |
|
Selling,
general and administrative expenses |
|
13,601 |
|
|
|
13,008 |
|
|
|
41,939 |
|
|
|
36,241 |
|
Amortization of intangible assets |
|
3,867 |
|
|
|
608 |
|
|
|
11,263 |
|
|
|
1,668 |
|
Restructuring charges |
|
− |
|
|
|
70 |
|
|
|
69 |
|
|
|
70 |
|
|
Operating income |
|
23,953 |
|
|
|
9,367 |
|
|
|
65,763 |
|
|
|
27,087 |
|
Other
(expense) income |
|
|
|
|
|
|
|
|
Interest
expense, net |
|
(4,153 |
) |
|
|
(301 |
) |
|
|
(17,333 |
) |
|
|
(650 |
) |
|
Loss on the
extinguishment of debt |
|
(277 |
) |
|
|
− |
|
|
|
(6,368 |
) |
|
|
− |
|
|
Derivative
fair value gain |
|
1,365 |
|
|
|
− |
|
|
|
5,238 |
|
|
|
− |
|
|
Other,
net |
|
(200 |
) |
|
|
144 |
|
|
|
(977 |
) |
|
|
88 |
|
|
Total other (expense)
income, net |
|
(3,265 |
) |
|
|
(157 |
) |
|
|
(19,440 |
) |
|
|
(562 |
) |
|
|
|
|
|
|
|
|
Income
before income taxes |
|
20,688 |
|
|
|
9,210 |
|
|
|
46,323 |
|
|
|
26,525 |
|
|
Provision for income
taxes |
|
(5,043 |
) |
|
|
(3,143 |
) |
|
|
509 |
|
|
|
(8,232 |
) |
Net
income |
$15,645 |
|
|
$6,067 |
|
|
$46,832 |
|
|
$18,293 |
|
Earnings
per share: |
|
|
|
|
|
|
|
|
Net income
per common share basic |
$1.01 |
|
|
$0.51 |
|
|
$3.24 |
|
|
$1.54 |
|
|
Net income
per common share diluted |
$0.98 |
|
|
$0.49 |
|
|
$3.16 |
|
|
$1.50 |
|
|
|
|
|
|
|
|
|
Weighted
average shares outstanding: |
|
|
|
|
|
|
|
|
Basic |
|
15,505 |
|
|
|
11,888 |
|
|
|
14,439 |
|
|
|
11,884 |
|
|
Diluted |
|
15,905 |
|
|
|
12,303 |
|
|
|
14,814 |
|
|
|
12,236 |
|
|
KMG CHEMICALS, INC. AND
SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE
SHEETS (In thousands, except for share and
per share amounts) |
|
|
April 30, |
July 31, |
|
|
2018 |
|
|
2017 |
|
|
(Unaudited) |
|
Assets |
|
|
Current assets |
|
|
Cash and cash
equivalents |
$21,818 |
|
$20,708 |
|
Accounts
receivable |
|
|
Trade, net of
allowances of $235 at April 30, 2018 and $263 at July 31,
2017 |
|
59,422 |
|
|
51,168 |
|
Other |
|
7,176 |
|
|
6,168 |
|
Inventories, net |
|
54,087 |
|
|
46,482 |
|
Prepaid expenses and
other |
|
4,305 |
|
|
8,617 |
|
Total current
assets |
|
146,808 |
|
|
133,143 |
|
|
|
|
Property, plant and
equipment, net |
|
114,640 |
|
|
105,435 |
|
Goodwill |
|
227,797 |
|
|
224,391 |
|
Intangible assets,
net |
|
303,318 |
|
|
320,401 |
|
Other assets, net |
|
12,744 |
|
|
9,061 |
|
Total assets |
$805,307 |
|
$792,431 |
|
|
|
|
Liabilities
& stockholders’ equity |
|
|
Current
liabilities |
|
|
Accounts payable |
$37,907 |
|
$29,570 |
|
Accrued
liabilities |
|
10,884 |
|
|
12,456 |
|
Employee incentive
accrual |
|
5,574 |
|
|
7,713 |
|
Current portion of
long-term debt |
|
− |
|
|
3,167 |
|
Total current
liabilities |
|
54,365 |
|
|
52,906 |
|
|
|
|
Long-term debt |
|
323,550 |
|
|
523,102 |
|
Deferred tax
liabilities |
|
23,243 |
|
|
37,944 |
|
Other long-term
liabilities |
|
5,446 |
|
|
4,763 |
|
Total liabilities |
|
406,604 |
|
|
618,715 |
|
|
|
|
Commitments and
contingencies |
|
|
|
|
|
Stockholders’
equity |
|
|
Preferred stock, $.01
par value, 10,000,000 shares authorized, none issued |
|
− |
|
|
− |
|
Common stock,
$.01 par value, 40,000,000 shares authorized, 15,505,350 shares
issued and outstanding at April 30, 2018 and 11,889,649 shares
issued and outstanding at July 31, 2017 |
|
155 |
|
|
119 |
|
Additional paid-in
capital |
|
220,094 |
|
|
42,535 |
|
Accumulated other
comprehensive loss |
|
(7,864 |
) |
|
(9,712 |
) |
Retained earnings |
|
186,318 |
|
|
140,774 |
|
Total stockholders’
equity |
|
398,703 |
|
|
173,716 |
|
Total liabilities and
stockholders’ equity |
$805,307 |
|
$792,431 |
|
|
KMG CHEMICALS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH
FLOWS(UNAUDITED) (In
thousands) |
|
|
|
Nine Months Ended |
|
|
|
April 30, |
|
|
|
2018 |
|
|
2017 |
|
Cash flows from
operating activities |
|
|
|
|
|
|
|
|
Net
income |
|
$46,832 |
|
|
$18,293 |
|
Adjustments to reconcile net income to net cash provided by
operating activities |
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
22,359 |
|
|
|
10,864 |
|
Loss on
extinguishment of debt |
|
|
6,368 |
|
|
|
− |
|
Stock-based compensation expense |
|
|
5,687 |
|
|
|
4,280 |
|
Amortization of debt discounts and financing costs included in
interest expense |
|
|
1,124 |
|
|
|
125 |
|
Debt
repricing transaction costs |
|
|
607 |
|
|
|
− |
|
Deferred
income tax benefit |
|
|
(9,097 |
) |
|
|
(1,189 |
) |
Derivative fair value gain |
|
|
(5,238 |
) |
|
|
− |
|
Other |
|
|
(65 |
) |
|
|
(935 |
) |
Changes
in operating assets and liabilities |
|
|
|
|
|
|
|
|
Accounts
receivable — trade |
|
|
(7,664 |
) |
|
|
(3,172 |
) |
Accounts
receivable — other |
|
|
(50 |
) |
|
|
2,253 |
|
Inventories |
|
|
(7,238 |
) |
|
|
606 |
|
Other
current and noncurrent assets |
|
|
(715 |
) |
|
|
(1,062 |
) |
Accounts
payable |
|
|
8,194 |
|
|
|
(1,282 |
) |
Accrued
liabilities and other |
|
|
(3,349 |
) |
|
|
(1,444 |
) |
Net cash
provided by operating activities |
|
|
57,755 |
|
|
|
27,337 |
|
|
|
|
|
|
|
|
|
|
Cash flows from
investing activities |
|
|
|
|
|
|
|
|
Additions
to property, plant and equipment |
|
|
(15,527 |
) |
|
|
(8,586 |
) |
Purchase
of Sealweld, net of cash acquired |
|
|
(585 |
) |
|
|
(16,584 |
) |
Other
investing activities |
|
|
(577 |
) |
|
|
− |
|
Proceeds
− insurance claim |
|
|
− |
|
|
|
1,247 |
|
Net cash
used in investing activities |
|
|
(16,689 |
) |
|
|
(23,923 |
) |
|
|
|
|
|
|
|
|
|
Cash flows from
financing activities |
|
|
|
|
|
|
|
|
Proceeds
from sale of common stock, net of issuance costs |
|
|
175,669 |
|
|
|
− |
|
Borrowings under credit facility |
|
|
− |
|
|
|
17,000 |
|
Payments
under credit facility |
|
|
− |
|
|
|
(18,800 |
) |
Principal
payments on borrowings on term loan |
|
|
(210,000 |
) |
|
|
− |
|
Debt
repricing transaction costs |
|
|
(607 |
) |
|
|
− |
|
Payment
of dividends |
|
|
(1,288 |
) |
|
|
(1,066 |
) |
Cash
payments related to tax withholdings from stock-based awards |
|
|
(3,729 |
) |
|
|
(277 |
) |
Net cash
used in financing activities |
|
|
(39,955 |
) |
|
|
(3,143 |
) |
|
|
|
|
|
|
|
|
|
Effect of exchange rate
changes on cash |
|
|
(1 |
) |
|
|
398 |
|
Net increase in cash,
cash equivalents and restricted cash |
|
|
1,110 |
|
|
|
669 |
|
|
|
|
|
|
|
|
|
|
Cash, cash equivalents
and restricted cash at beginning of period |
|
|
20,708 |
|
|
|
13,428 |
|
Cash, cash equivalents
and restricted cash at end of period |
|
$21,818 |
|
|
$14,097 |
|
Reconciliation of GAAP financial measures to non-GAAP
financial measuresKMG provides non-GAAP financial
information to complement reported GAAP results. KMG believes that
analysis of our financial performance would be enhanced by an
understanding of the factors underlying that performance and our
judgments about the likelihood that particular factors will repeat.
We define adjusted EBITDA as earnings from operations before
interest, taxes, depreciation, amortization, acquisition and
integration expenses, restructuring and realignment charges and
other relevant items.
KMG intends to continue to provide certain non-GAAP financial
information and the appropriate reconciliation to GAAP in its
financial results. As required by SEC rules, the tables below
present a reconciliation of our presented non-GAAP measures to the
most directly comparable GAAP measures. These non-GAAP measures
should be viewed as a supplement to, and not a substitute for, U.S.
GAAP measures of performance.
Table 1RECONCILIATION OF CONSOLIDATED
GAAP NET INCOME TO CONSOLIDATED ADJUSTED EBITDA
(in
thousands) |
Third QuarterFiscal
2018 |
Third QuarterFiscal
2017 |
Consolidated GAAP net
income |
$15,645 |
|
$ 6,067 |
Add back: |
|
|
Interest
expense, net |
|
4,153 |
|
|
301 |
Income
taxes |
|
5,043 |
|
|
3,143 |
Depreciation & amortization |
|
7,664 |
|
|
3,817 |
Loss on
the extinguishment of debt |
|
277 |
|
|
− |
Derivative fair value gain |
|
(1,365 |
) |
|
− |
Debt
repricing transaction costs |
|
5 |
|
|
− |
Acquisition & integration expenses |
|
48 |
|
|
562 |
Corporate
relocation expense |
|
− |
|
|
2 |
Restructuring charges, excluding accelerated depreciation |
|
− |
|
|
70 |
Consolidated adjusted
EBITDA |
$31,470 |
|
$13,962 |
|
(in
thousands) |
Nine Months EndedApril 30,
2018 |
Nine Months Ended April 30, 2017 |
Consolidated GAAP net
income |
$46,832 |
|
$18,293 |
Add back: |
|
|
Interest
expense, net |
|
17,333 |
|
|
650 |
Income
taxes |
|
(509 |
) |
|
8,232 |
Depreciation & amortization |
|
22,359 |
|
|
10,864 |
Loss on
the extinguishment of debt |
|
6,368 |
|
|
− |
Derivative fair value gain |
|
(5,238 |
) |
|
− |
Debt
repricing transaction costs |
|
607 |
|
|
− |
Acquisition & integration expenses |
|
578 |
|
|
1,145 |
Corporate
relocation expense |
|
− |
|
|
369 |
Restructuring charges, excluding accelerated depreciation |
|
69 |
|
|
70 |
Consolidated adjusted
EBITDA |
$88,399 |
|
$39,623 |
|
Table 1ARECONCILIATION OF OPERATING
INCOME TO ADJUSTED EBITDANote that we do not allocate
certain financial statement line items below operating income to
our segments; as such, the reconciliations below only reflect the
reconciliation of our operating income by segment to our non-GAAP
measures.
Third Quarter
Fiscal 2018 |
Electronic |
Performance |
|
|
(in thousands) |
Chemicals |
Materials |
Corporate |
Total |
Operating
Income (Loss) |
$10,889 |
|
$16,041 |
|
($2,977 |
) |
$23,953 |
|
Other income
(expense) |
|
(33 |
) |
|
(96 |
) |
|
(71 |
) |
|
(200 |
) |
Depreciation and
amortization |
|
2,864 |
|
|
4,250 |
|
|
550 |
|
|
7,664 |
|
Acquisition &
integration expenses |
|
— |
|
|
28 |
|
|
20 |
|
|
48 |
|
Debt repricing
costs |
|
— |
|
|
— |
|
|
5 |
|
|
5 |
|
Restructuring
charges |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Adjusted
EBITDA |
|
13,720 |
|
|
20,223 |
|
|
(2,473 |
) |
|
31,470 |
|
Corporate
allocation |
|
3,034 |
|
|
1,964 |
|
|
(4,999 |
) |
|
— |
|
Adjusted EBITDA
excl. corporate allocation |
$16,754 |
|
$22,188 |
|
($7,472 |
) |
$31,470 |
|
|
|
|
|
|
Nine Months
Ended April 30, 2018 |
Electronic |
Performance |
|
|
(in thousands) |
Chemicals |
Materials |
Corporate |
Total |
Operating
Income (Loss) |
$34,877 |
|
$40,435 |
|
($9,549 |
) |
$65,763 |
|
Other income
(expense) |
|
(616 |
) |
|
(41 |
) |
|
(320 |
) |
|
(977 |
) |
Depreciation and
amortization |
|
8,418 |
|
|
12,418 |
|
|
1,523 |
|
|
22,359 |
|
Acquisition &
integration expenses |
|
— |
|
|
125 |
|
|
453 |
|
|
578 |
|
Debt repricing
transaction costs |
|
— |
|
|
— |
|
|
607 |
|
|
607 |
|
Restructuring
charges |
|
69 |
|
|
— |
|
|
— |
|
|
69 |
|
Adjusted
EBITDA |
|
42,748 |
|
|
52,937 |
|
|
(7,286 |
) |
|
88,399 |
|
Corporate
allocation |
|
9,103 |
|
|
5,893 |
|
|
(14,997 |
) |
|
— |
|
Adjusted EBITDA
excl. corporate allocation |
$51,851 |
|
$58,831 |
|
($22,283 |
) |
$88,399 |
|
|
Third Quarter
Fiscal 2017 |
Electronic |
Performance |
|
|
(in thousands) |
Chemicals |
Materials |
Corporate |
Total |
Operating
Income (Loss) |
$8,509 |
$4,224 |
($3,366 |
) |
$9,367 |
Other income
(expense) |
|
99 |
|
33 |
|
12 |
|
|
144 |
Depreciation and
amortization |
|
2,857 |
|
549 |
|
411 |
|
|
3,817 |
Acquisition &
integration expenses |
|
— |
|
— |
|
562 |
|
|
562 |
Restructuring
charges |
|
— |
|
— |
|
70 |
|
|
70 |
Corporate relocation
expense |
|
— |
|
— |
|
2 |
|
|
2 |
Adjusted
EBITDA |
|
11,465 |
|
4,806 |
|
(2,309 |
) |
|
13,962 |
Corporate
allocation |
|
3,329 |
|
842 |
|
(4,171 |
) |
|
— |
Adjusted EBITDA
excl. corporate allocation |
$14,794 |
$5,648 |
($6,480 |
) |
$13,962 |
|
|
|
|
|
Nine Months
Ended April 30, 2017 |
Electronic |
Performance |
|
|
(in thousands) |
Chemicals |
Materials |
Corporate |
Total |
Operating
Income (Loss) |
$26,153 |
|
$10,927 |
($9,993 |
) |
$27,087 |
Other income
(expense) |
|
(88 |
) |
|
66 |
|
110 |
|
|
88 |
Depreciation and
amortization |
|
8,502 |
|
|
1,121 |
|
1,241 |
|
|
10,864 |
Acquisition &
integration expenses |
|
— |
|
|
— |
|
1,145 |
|
|
1,145 |
Restructuring
charges |
|
— |
|
|
— |
|
70 |
|
|
70 |
Corporate relocation
expense |
|
— |
|
|
— |
|
369 |
|
|
369 |
Adjusted
EBITDA |
|
34,567 |
|
|
12,114 |
|
(7,058 |
) |
|
39,623 |
Corporate
allocation |
|
9,987 |
|
|
2,527 |
|
(12,514 |
) |
|
— |
Adjusted EBITDA
excl. corporate allocation |
$44,554 |
|
$14,641 |
($19,572 |
) |
$39,623 |
Table 2RECONCILIATION OF NET INCOME TO
ADJUSTED NET INCOME AND ADJUSTED DILUTED EARNINGS PER
SHARE (in thousands)
|
Three Months Ended |
|
April 30, |
|
|
2018 |
|
|
|
2017 |
|
Net income |
$15,645 |
|
|
$6,067 |
|
Items impacting pre-tax
income: |
|
|
|
Impact of
the Tax Cuts and Jobs Act |
|
− |
|
|
|
− |
|
Acquisition & integration expenses |
|
48 |
|
|
|
562 |
|
Corporate
relocation expense |
|
− |
|
|
|
2 |
|
Restructuring charges |
|
− |
|
|
|
70 |
|
Derivative fair value gain |
|
(1,365 |
) |
|
|
− |
|
Amortization of Flowchem intangible assets |
|
3,224 |
|
|
|
− |
|
Loss on
the extinguishment of debt |
|
277 |
|
|
|
− |
|
Debt
repricing transaction costs |
|
5 |
|
|
|
− |
|
Amortization of debt discounts and financing costs |
|
296 |
|
|
|
− |
|
Income
taxes * |
|
(671 |
) |
|
|
(222 |
) |
Adjusted net income
** |
$17,459 |
|
|
$6,479 |
|
Adjusted diluted
earnings per share ** |
$ 1.10 |
|
|
$0.53 |
|
Weighted average
diluted shares outstanding |
|
15,905 |
|
|
|
12,303 |
|
|
|
Nine Months Ended |
|
|
April 30, |
|
|
|
2018 |
|
|
|
2017 |
|
Net income |
$46,832 |
|
|
$18,293 |
|
Items impacting pre-tax
income: |
|
|
|
|
Impact of
the Tax Cuts and Jobs Act |
|
(11,005 |
) |
|
|
− |
|
Acquisition & integration expenses |
|
578 |
|
|
|
1,145 |
|
Corporate
relocation expense |
|
− |
|
|
|
369 |
|
Restructuring charges |
|
69 |
|
|
|
70 |
|
Derivative fair value gain |
|
(5,238 |
) |
|
|
− |
|
Amortization of Flowchem intangible assets |
|
9,339 |
|
|
|
− |
|
Loss on
the extinguishment of debt |
|
6,368 |
|
|
|
− |
|
Debt
repricing transaction costs |
|
607 |
|
|
|
− |
|
Amortization of debt discounts and financing costs |
|
1,124 |
|
|
|
− |
|
Income
taxes * |
|
(3,469 |
) |
|
|
(554) |
|
Adjusted net income
** |
$45,205 |
|
|
$19,323 |
|
Adjusted diluted
earnings per share ** |
$3.05 |
|
|
$ 1.58 |
|
Weighted average
diluted shares outstanding |
|
14,814 |
|
|
12,236 |
|
*
For the three and nine months ended April 30, 2018, represents the
aggregate tax-effect assuming a 27% tax rate of the items impacting
pre-tax income, which is our estimated U.S. statutory federal tax
rate for fiscal year 2018 following the Tax Act in December 2017.
For the three and nine months ended April 30, 2017, represents the
aggregate tax-effect assuming a 35% tax rate of items impacting
pre-tax income.** Adjusted net income and adjusted diluted earnings
per share for the first quarter of fiscal 2018, which are included
in the nine months ended April 30, 2018, have been adjusted to
reflect the assumed 27% tax rate for fiscal year 2018. |
|
Table 2ARECONCILIATION OF GAAP
FINANCIAL MEASURES TO NON-GAAP FINANCIAL MEASURES
Third Quarter
Fiscal 2018 |
KMG Chemicals, Inc. |
Dollars
in thousands, except EPS |
|
|
Operating |
|
Net |
|
Diluted Earnings |
Income |
|
Margin |
|
Income |
|
Per Share |
GAAP measure |
$23,953 |
|
20.2 |
% |
|
$15,645 |
|
|
$0.98 |
|
Amortization of
Flowchem intangible assets |
|
3,224 |
|
2.7 |
% |
|
|
2,354 |
|
|
|
0.15 |
|
Acquisition &
integration expenses |
|
48 |
|
0.1 |
% |
|
|
35 |
|
|
|
0.01 |
|
Debt repricing
transaction costs |
|
5 |
|
0.0 |
% |
|
|
4 |
|
|
|
0.00 |
|
Derivative fair value
gain |
|
— |
|
— |
|
|
|
(996 |
) |
|
|
(0.06 |
) |
Amortization of debt
discounts and financing costs |
|
— |
|
— |
|
|
|
216 |
|
|
|
0.01 |
|
Loss on the
extinguishment of debt |
|
— |
|
— |
|
|
|
202 |
|
|
|
0.01 |
|
Non-GAAP measure |
$27,230 |
|
23.0 |
% |
|
$17,459 |
|
|
$1.10 |
|
Nine Months
Ended April 30, 2018 |
KMG Chemicals, Inc. |
Dollars
in thousands, except EPS |
|
|
Operating |
|
Net |
|
Diluted Earnings |
Income |
|
Margin |
|
Income |
|
Per Share |
GAAP measure |
$65,763 |
|
19.2 |
% |
|
$46,832 |
|
|
$3.16 |
|
Amortization of
Flowchem intangible assets |
|
9,339 |
|
2.7 |
% |
|
|
6,817 |
|
|
|
0.46 |
|
Acquisition &
integration expenses |
|
578 |
|
0.2 |
% |
|
|
422 |
|
|
|
0.03 |
|
Restructuring
charges |
|
69 |
|
0.0 |
% |
|
|
50 |
|
|
|
0.00 |
|
Impact of the Tax Cuts
and Jobs Act |
|
— |
|
— |
|
|
|
(11,005 |
) |
|
|
(0.74 |
) |
Loss on the
extinguishment of debt |
|
— |
|
— |
|
|
|
4,649 |
|
|
|
0.31 |
|
Derivative fair value
gain |
|
— |
|
— |
|
|
|
(3,824 |
) |
|
|
(0.26 |
) |
Amortization of debt
discounts and financing costs |
|
— |
|
— |
|
|
|
821 |
|
|
|
0.06 |
|
Debt repricing
transaction costs |
|
— |
|
— |
|
|
|
443 |
|
|
|
0.03 |
|
Non-GAAP measure |
$75,749 |
|
22.1 |
% |
|
$45,205 |
|
|
$3.05 |
|
Third Quarter
Fiscal 2017 |
KMG Chemicals, Inc. |
Dollars
in thousands, except EPS |
|
|
Operating |
|
Net |
|
Diluted Earnings |
Income |
|
Margin |
|
Income |
|
Per Share |
GAAP
measure |
$ 9,367 |
|
11.5 |
% |
|
$6,067 |
|
$0.49 |
Acquisition & integration expenses |
|
562 |
|
0.7 |
% |
|
|
365 |
|
0.03 |
Restructuring & realignment charges |
|
70 |
|
0.1 |
% |
|
|
46 |
|
0.01 |
Corporate
relocation expense |
|
2 |
|
0.0 |
% |
|
|
1 |
|
0.00 |
Non-GAAP
measure |
$10,001 |
|
12.3 |
% |
|
$6,479 |
|
$0.53 |
Nine Months
Ended April 30, 2017 |
KMG Chemicals, Inc. |
Dollars
in thousands, except EPS |
|
|
Operating |
|
Net |
|
Diluted Earnings |
Income |
|
Margin |
|
Income |
|
Per Share |
GAAP
measure |
$ 27,087 |
|
11.4 |
% |
|
$18,293 |
|
$1.50 |
Acquisition & integration expenses |
|
1,145 |
|
0.5 |
% |
|
|
744 |
|
0.06 |
Restructuring & realignment charges |
|
70 |
|
0.0 |
% |
|
|
46 |
|
0.00 |
Corporate
relocation expense |
|
369 |
|
0.2 |
% |
|
|
240 |
|
0.02 |
Non-GAAP
measure |
$ 28,671 |
|
12.1 |
% |
|
$19,323 |
|
$1.58 |
KMG Investor Relations
Eric Glover, 817-761-6006
eglover@kmgchemicals.com
Kerr Mcgee (NYSE:KMG)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024
Kerr Mcgee (NYSE:KMG)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024